NM_014845.6:c.447-16G>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_014845.6(FIG4):c.447-16G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0068 in 1,015,068 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0060 ( 4 hom., cov: 26)
Exomes 𝑓: 0.0069 ( 29 hom. )
Consequence
FIG4
NM_014845.6 intron
NM_014845.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.161
Publications
1 publications found
Genes affected
FIG4 (HGNC:16873): (FIG4 phosphoinositide 5-phosphatase) The protein encoded by this gene belongs to the SAC domain-containing protein gene family. The SAC domain, approximately 400 amino acids in length and consisting of seven conserved motifs, has been shown to possess phosphoinositide phosphatase activity. The yeast homolog, Sac1p, is involved in the regulation of various phosphoinositides, and affects diverse cellular functions such as actin cytoskeleton organization, Golgi function, and maintenance of vacuole morphology. Membrane-bound phosphoinositides function as signaling molecules and play a key role in vesicle trafficking in eukaryotic cells. Mutations in this gene have been associated with Charcot-Marie-Tooth disease, type 4J. [provided by RefSeq, Jul 2008]
FIG4 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- Charcot-Marie-Tooth disease type 4JInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine
- Yunis-Varon syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
- amyotrophic lateral sclerosis type 11Inheritance: Unknown, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- bilateral parasagittal parieto-occipital polymicrogyriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 6-109732621-G-T is Benign according to our data. Variant chr6-109732621-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 4 AR,Unknown,AD gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FIG4 | ENST00000230124.8 | c.447-16G>T | intron_variant | Intron 4 of 22 | 1 | NM_014845.6 | ENSP00000230124.4 |
Frequencies
GnomAD3 genomes AF: 0.00599 AC: 882AN: 147352Hom.: 4 Cov.: 26 show subpopulations
GnomAD3 genomes
AF:
AC:
882
AN:
147352
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00542 AC: 891AN: 164298 AF XY: 0.00543 show subpopulations
GnomAD2 exomes
AF:
AC:
891
AN:
164298
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00693 AC: 6017AN: 867668Hom.: 29 Cov.: 14 AF XY: 0.00677 AC XY: 3050AN XY: 450550 show subpopulations
GnomAD4 exome
AF:
AC:
6017
AN:
867668
Hom.:
Cov.:
14
AF XY:
AC XY:
3050
AN XY:
450550
show subpopulations
African (AFR)
AF:
AC:
51
AN:
19906
American (AMR)
AF:
AC:
162
AN:
38076
Ashkenazi Jewish (ASJ)
AF:
AC:
140
AN:
20600
East Asian (EAS)
AF:
AC:
30
AN:
33756
South Asian (SAS)
AF:
AC:
114
AN:
68934
European-Finnish (FIN)
AF:
AC:
201
AN:
35760
Middle Eastern (MID)
AF:
AC:
34
AN:
4236
European-Non Finnish (NFE)
AF:
AC:
5013
AN:
606932
Other (OTH)
AF:
AC:
272
AN:
39468
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
237
474
711
948
1185
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
126
252
378
504
630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00598 AC: 882AN: 147400Hom.: 4 Cov.: 26 AF XY: 0.00574 AC XY: 411AN XY: 71602 show subpopulations
GnomAD4 genome
AF:
AC:
882
AN:
147400
Hom.:
Cov.:
26
AF XY:
AC XY:
411
AN XY:
71602
show subpopulations
African (AFR)
AF:
AC:
99
AN:
40318
American (AMR)
AF:
AC:
80
AN:
14788
Ashkenazi Jewish (ASJ)
AF:
AC:
26
AN:
3440
East Asian (EAS)
AF:
AC:
6
AN:
5050
South Asian (SAS)
AF:
AC:
8
AN:
4688
European-Finnish (FIN)
AF:
AC:
38
AN:
9110
Middle Eastern (MID)
AF:
AC:
3
AN:
288
European-Non Finnish (NFE)
AF:
AC:
611
AN:
66790
Other (OTH)
AF:
AC:
11
AN:
2024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
45
90
135
180
225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
FIG4: BS2
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
not specified Benign:2
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Charcot-Marie-Tooth disease Benign:1
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Yunis-Varon syndrome;C1970011:Charcot-Marie-Tooth disease type 4J;C2675491:Amyotrophic lateral sclerosis type 11;C4013648:Bilateral parasagittal parieto-occipital polymicrogyria Benign:1
May 09, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Charcot-Marie-Tooth disease type 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.